FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← XERS · Xeris Biopharma Holdings, Inc.
DEFA14AThe Ballot

Xeris Biopharma Holdings, Inc. files DEFA14A

Filed Apr 28, 2022 · 4y ago · Accession 0001867096-22-000048

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Xeris Biopharma Holdings, Inc.
Ticker
XERS
CIK
1867096
Form type
DEFA14A
Filing date
Apr 28, 2022
Report date
—
Document
a2022proxystatementdefa14a.htm
Size
247 KB

More from XERS

8-KEquity Issuance · Company UpdateJun 11, 20268-KShareholder VoteJun 5, 202610-QThe RecordMay 7, 20268-KResults of OperationsMay 7, 2026DEF 14AThe BallotApr 23, 2026DEFA14AThe BallotApr 23, 2026